• Source: O-1057

      • O-1057 is an analgesic cannabinoid derivative created by Organix Inc., Newburyport, Massachusetts, for use in scientific research. Unlike most cannabinoids discovered to date, it is water-soluble, which gives it considerable advantages over many related cannabinoids. It has moderate affinity for both CB1 and CB2 receptors, with Ki values of 8.36 nM at CB1 and 7.95 nM at CB2


      See also


      AM-2232
      O-774
      O-1812
      O-2694
      SP-111


      References

    Kata Kunci Pencarian: